ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
4,964.22
-0.94%
US Tech 100
16,573.40
-2.14%
Dow Jones
37,919.82
0.38%
Brent Oil
86.795
0.44%
Bitcoin
64,257.40
1.16%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Telesis Bio Inc (TBIO) Quote

Telesis Bio Inc

Telesis Bio Inc (TBIO)

NASDAQ
0.3045
-0.0265
( -8.01% )
Updated: 14:55:05
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.3045
Bid
0.302
Ask
0.3045
Volume
110,419
0.30 Day's Range 0.35
0.30 52 Week Range 3.01
Market Cap
8.995M
Previous Close
0.331
Open
0.32
Last Trade
100
@
0.3045
Last Trade Time
14:53:07
Financial Volume
$ 35,587
VWAP
0.32229
Average Volume (3m)
784,350
Shares Outstanding
29,983,709
Dividend Yield
-
PE Ratio
-0.18
Earnings Per Share (EPS)
-1.64
Revenue
27.51M
Net Profit
-49.02M

About Telesis Bio Inc

Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of... Telesis Bio Inc. is engaged in providing automated multi-omic and synthetic biology solutions. The Company's synthetic biology solution addresses the bottlenecks across the multi-step process of building deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA), as well as the limitations of solutions that prevent the building of virtually error-free DNA and mRNA at a useable scale. Its on-market and planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp DBC, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, BioXp DBC kits, Benchtop reagents and Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS). BioXp 3250 system is a push-button, walkaway, end-to-end automated workstation that offers endpoint-ready synthetic DNA in as few as 8 hours and mRNA in less than 24 hours. BioXp DBC is engaged in delivering on-demand enzymatic DNA synthesis with design-to-endpoint-ready synthetic RNA in as few as 24 hours. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
www.codexdna.com
Headquarters
Wilmington, Delaware, USA
Founded
1970
Telesis Bio Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker TBIO. The last closing price for Telesis Bio was $0.33. Over the last year, Telesis Bio shares have traded in a share price range of $ 0.30 to $ 3.01.

Telesis Bio currently has 29,983,709 shares outstanding. The market capitalization of Telesis Bio is $9 million. Telesis Bio has a price to earnings ratio (PE ratio) of -0.18.

TBIO Latest News

More News

Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership

SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the...

April 18 2024
GlobeNewswire Inc.

Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results

SAN DIEGO, March 28, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through...

March 28 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

March 05 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

March 05 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

March 05 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 29 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

February 29 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 26 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.1205-28.35294117650.4250.46410.3806660.34877339CS
4-0.142-31.80291153420.44650.490.3520580.4054375CS
12-0.0475-13.49431818180.3520.8590.37843500.61819247CS
26-0.6355-67.60638297870.9410.35027560.55825565CS
52-2.6855-89.81605351172.993.010.32775550.66894635CS
156-18.6055-98.389740877818.9137.9850.366831523.62211239CS
260-9.6855-96.9519519529.9937.9850.374268120.00948477CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWGTop Wealth Group Holding Ltd
$ 3.22
(74.05%)
31.28M
SHOTWSafety Shot Inc
$ 0.48
(60.00%)
6.71k
EGOXNext e GO NV
$ 0.0513
(42.50%)
322.99M
MNDRMobile health Network Solutions
$ 28.325
(39.05%)
8.16M
WISAWiSA Technologies Inc
$ 8.14
(38.20%)
31.45M
YYAIConnexa Sports Technologies Inc
$ 0.96
(-54.07%)
11.89M
SBFMSunshine Biopharma Inc
$ 1.83
(-44.88%)
9.92M
IPDNProfessional Diversity Network Inc
$ 1.0799
(-35.72%)
177.93k
GSUNGolden Sun Health Technology Group Ltd
$ 3.3037
(-32.59%)
57.76k
IONMAssure Holdings Corporation
$ 0.44
(-30.85%)
268.75k
EGOXNext e GO NV
$ 0.0513
(42.50%)
322.99M
SQQQProShares UltraPro Short QQQ
$ 12.885
(6.75%)
178.26M
AGBAAGBA Group Holding Ltd
$ 1.27
(23.30%)
119.67M
SINTSiNtx Technologies Inc
$ 0.0426
(6.50%)
100.75M
TQQQProShares UltraPro QQQ
$ 49.295
(-6.55%)
96.78M

TBIO Discussion

View Posts
TOM611 TOM611 2 months ago
Go. TBiO. Life. Enhancing. Patent
👍️0
Hikiro Hikiro 2 months ago
I personally see this consolidating Monday between .55 and .45
👍️0
glenn1919 glenn1919 2 months ago
TBIO...............................................https://stockcharts.com/h-sc/ui?s=TBIO&p=W&b=5&g=0&id=p86431144783
👍️0
XenaLives XenaLives 2 months ago
This one scares the crap out of me...

Imagine replication of COVID ( or the next worst thing) with out a biological matrix.

December 5, 2023 | LIVE WEBINAR
Unlocking the Potential of mRNA as a Tool for Immuno-Oncology Therapy Discovery and Development
Immuno-oncology is a rapidly growing area for therapeutic development. With the adoption of various autologous cell therapies and an increased focus on more broadly applicable allogeneic treatments and multi-specific therapies, the complexity of these development activities is also increasing. With this drive to increased complexity and the inherent risks associated with potential failure in Phase 1 clinical trials, it is critical to have a solid scientific foundation for the development of these next-generation immunotherapies. This talk will focus on how to overcome the limitations associated with traditional viral vector based recombinant TCR gene expression to build hundreds of candidates a week, resulting in improved confidence in screening and lead optimization. With the direct use of mRNA to drive transient modulation of cellular phenotypes, potential candidates can be screened quickly and cost-effectively. Come and learn how immuno-oncology researchers are automating synthetic biolological...



$TBIO Granted EUR Patent #3503915 For "GENETICALLY ENGINEERED VIBRIO NATRIEGENS (HOST ORGANISM FOR CLONING AND MANIPULATING DNA)".https://t.co/9dekeJkgGu pic.twitter.com/Mj3hMaJPML— Patent_Stocks (@US_Patent_Plays) February 22, 2024
👍️0
TOM611 TOM611 2 months ago
Wow, a patent to clone that’s incredible
👍️0
observer21 observer21 2 months ago
Gosh. Such wisdom. Thanks for enlightening us with that critical information.
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
dilutive bio stocks under 1.00 are like pink sheets on steroids...ya better know how to trade em or you will lose yo money fast!!!
👍️0
Invest-in-America Invest-in-America 2 months ago
TBIO: Right here in my San Diego --- grab some?????
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
Chart plays are never tricky. Stick to bullish stocks. Day trading pop and drops, ya better have skills and understand intraday 60 min charting, order flow and how to spot the shorts.
👍️0
TimeFades TimeFades 2 months ago
Tricky day
👍️0
Awl416 Awl416 2 months ago
New highs AH
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
LETS JUST SAY MOST AH POPS ARE DILUTION, ESPECIALLY THE BIO SPACE.
👍️0
TheFinalCD TheFinalCD 2 months ago
THX
👍️0
TimeFades TimeFades 2 months ago
Another short opp
👍️0
TrendTrade2016 TrendTrade2016 2 months ago
AFTER HOUR DILUTION TAKING PLACE...CHASE AND CRY PLAY!
👍️0
Awl416 Awl416 2 months ago
What leaked?
👍️0
Zorro Zorro 2 months ago
Nice one!
👍️0
Invest-in-America Invest-in-America 2 months ago
TBIO: VIBRIO NATRIEGENS (So, what's NEW, Pussycat??!!)

👍️0
TheFinalCD TheFinalCD 2 months ago
$TBIO Granted EUR Patent #3503915 For "GENETICALLY ENGINEERED VIBRIO NATRIEGENS (HOST ORGANISM FOR CLONING AND MANIPULATING DNA)".https://t.co/9dekeJkgGu pic.twitter.com/Mj3hMaJPML— Patent_Stocks (@US_Patent_Plays) February 22, 2024
👍️0
observer21 observer21 3 months ago
Anyone know why the huge jump in price and volume?
👍️0

Your Recent History

NASDAQ
TBIO
Telesis Bio
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved